Since formation of the EWS-FLI1-RHA complex enhances EWS-FLI1 oncogenic activity and tumor maintenance [86], the possibility to modulate, or even inhibit, this interaction could have enormous therapeutic value in Ewing sarcoma. The gene discussed is DHX9; the disease is neoplasm.